Potential curative treatment combination for stage IIA/B seminoma

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Sep 19 / Springer Healthcare

Potential curative treatment combination for stage IIA/B seminoma

Oncology Urogenital Cancer ESMO-2021

Description

Robert Huddart provides his thoughts on the phase 2 SAKK 01/10 trial looking at single-dose carboplatin AUC7 and involved-node radiotherapy for men with stage IIA/B seminoma.

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.